Miguel ESCOBAR
The University of Texas Health Science Center, Houston · Memorial Hermann Texas Medical Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Miguel ESCOBAR as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 05:24 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT05695391 · Safety and Efficacy of FVIIa to Prevent Excessive Bleeding in Hemophilia Patients With Inhibitors Undergoing Major SurgeryLaboratoire français de Fractionnement et de Biotechnologies · terminated · Hemophilia · principal investigator
- Ph3NCT02548143 · LR769 in Congenital Hemophilia Patients With Inhibitors Undergoing Elective Surgery or Invasive ProceduresLaboratoire français de Fractionnement et de Biotechnologies · completed · Hemophilia · principal investigator
- N/ANCT00178607 · Covalent Tolerance Induction to Factor VIII-Prediction of Inhibitors in HemophiliaThe University of Texas Health Science Center, Houston · completed · Hemophilia A · principal investigator
- N/ANCT00178594 · Evaluation of Hemostasis in Bleeding and Thrombotic DisordersThe University of Texas Health Science Center, Houston · recruiting · Blood Coagulation Disorders, Inherited, Thrombotic Disorder · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 05:24 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Omic Approaches to Factor VIII Inhibitor Development in Hemophilia Patients of Mexican DescentR01HL169763 · NHLBI · UNIVERSITY OF TEXAS RIO GRANDE VALLEY · fiscal years 2024 to 2026 · $658,485 awarded in 2026Same name and institution; not confirmed by an ID
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 05:24 UTC. The ranking covers the 200 most relevant of 40 PubMed records, and a shared surname and initials can bring in a namesake. All 40 on PubMed
- Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B.N Engl J Med · 2023316 citationsRCR 33.0
- 176 citationsRCR 10.7
- Estrogen priming effect on growth hormone (GH) provocative test: a useful tool for the diagnosis of GH deficiency.J Clin Endocrinol Metab · 200091 citationsRCR 2.9
- 70 citationsRCR 3.1
- The effect of early dexamethasone administration on bronchopulmonary dysplasia in preterm infants with respiratory distress syndrome.J Pediatr · 199853 citationsRCR 2.3
- 50 citationsRCR 2.3
- Dengue vector management using insecticide treated materials and targeted interventions on productive breeding-sites in Guatemala.BMC Public Health · 201244 citationsRCR 1.8
- High diagnostic accuracy of subcutaneous Triptorelin test compared with GnRH test for diagnosing central precocious puberty in girls.Clin Endocrinol (Oxf) · 201341 citationsRCR 1.9
- 38 citationsRCR 3.4
- Using a multidisciplinary and evidence-based approach to decrease undertriage and overtriage of pediatric trauma patients.J Pediatr Surg · 201632 citationsRCR 2.2